Home LiteratureArticle Details
PMID: 2575930 Published · ppublish English Journal Article Review

Coexisting peptides in hypothalamic neuroendocrine systems: some functional implications.

Cellular and molecular neurobiology ·Vol. 9 ·No. 4 ·1989-12-00 ·Pages 427-46

Bondy CA, Whitnall MH, Brady LS, Gainer H

Abstract

1. Coexisting with oxytocin or vasopressin in the cell bodies and nerve terminals of the hypothalamic-neurohypophysial system are smaller amounts of other peptides. For a number of these "copeptides" there is strong evidence of corelease with the major magnocellular hormones. Guided by the location of their specific receptors we have studied the effects of three copeptides, dynorphin, cholecystokinin (CCK), and corticotropin releasing hormone (CRH), on the secretion of oxytocin and vasopressin from isolated rat neural lobe or neurointermediate lobe preparations in vitro. 2. Dynorphin is coreleased with vasopressin from neural lobe nerve terminals and acts on neural lobe kappa-opiate receptors to inhibit the electrically stimulated secretion of oxytocin. Naloxone augments oxytocin release from the neural lobe in a manner directly proportional to the amount of vasopressin (and presumably dynorphin) released. 3. Cholecystokinin, coreleased with oxytocin by neural lobe terminals, has been shown to have high-affinity receptors located in the NL and to stimulate secretion of both oxytocin and vasopressin. CCK's secretagogue effect was independent of electrical stimulation and extracellular Ca2+ and was blocked by an inhibitor of protein kinase C. 4. CRH, coreleased with OT from the neural lobe, has receptors in the intermediate lobe of the pituitary, but not in the neural lobe itself. CRH stimulates the secretion of oxytocin and vasopressin from combined neurointermediate lobes but not from isolated neural lobes. Intermediate lobe peptides, alpha and gamma melanocyte stimulating hormone, induced secretion of oxytocin and vasopressin from isolated neural lobes. Their effect was, like that of CCK, independent of electrical stimulation and extracellular Ca2+ and blocked by an inhibitor of protein kinase C. 5. Among the CRH-producing parvocellular neurons of the paraventricular nucleus, in the normal rat, approximately half also produce and store vasopressin. After removal of glucocorticoid influence by adrenalectomy, virtually all of the CRH neurons contain vasopressin. 6. The two subtypes of CRH neurosecretory cells found in the normal rat possess different topographical distributions in the paraventricular nucleus, suggesting the possibility of differential innervation. Stress selectively activates the vasopressin containing subpopulation of CRH neurons, indicating that there are separate channels of regulatory input controlling the two components of the parvocellular CRH neurosecretory system.

MeSH Terms
Animals Cholecystokinin/pharmacology Corticotropin-Releasing Hormone/pharmacology Dynorphins/pharmacology Hypothalamus/metabolism Oxytocin/metabolism Rats Vasopressins/metabolism
Chemicals
Vasopressins Oxytocin Dynorphins Cholecystokinin Corticotropin-Releasing Hormone
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Bondy C A
Laboratory of Neurochemistry, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892.
Whitnall M H
Brady L S
Gainer H
References (81)
81 references, click to expand
  1. Substance P regulates the vasodilator activity of calcitonin gene-related peptide.
    Nature. 1988 Sep 1;335(6185):73-5 PMID: 2457810
  2. Corticosteroid inhibition of ACTH secretion.
    Endocr Rev. 1984 Winter;5(1):1-24 PMID: 6323158
  3. Fine structure and cytochemistry of the mammalian pars intermedia.
    Ciba Found Symp. 1981;81:101-27 PMID: 6268374
  4. Evidence for opiate receptors on pituicytes.
    Nature. 1983 Sep 15-21;305(5931):235-7 PMID: 6310415
  5. Multiple co-existence of peptides and classical transmitters in peripheral autonomic and sensory neurons--functional and pharmacological implications.
    Prog Brain Res. 1986;68:241-62 PMID: 2882554
  6. Coexistence of neuronal messengers: a new principle in chemical transmission. Proceedings of the Marcus Wallenberg Symposium. Stockholm, 26-28 June, 1985.
    Prog Brain Res. 1986;68:1-411 PMID: 2882546
  7. Cholecystokinin varies in the posterior pituitary and external median eminence of the rat according to factors affecting vasopressin and oxytocin.
    Life Sci. 1983 May 30;32(22):2571-7 PMID: 6855457
  8. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin.
    Science. 1981 Sep 18;213(4514):1394-7 PMID: 6267699
  9. Co-existence of unrelated peptides in oxytocin and vasopressin terminals of rat neurohypophyses: immunoreactive methionine-enkephalin-, leucine-enkephalin- and cholecystokinin-like substances.
    Neuroscience. 1983;8(2):213-27 PMID: 6341877
  10. Calcitonin gene-related peptide enhances the rate of desensitization of the nicotinic acetylcholine receptor in cultured mouse muscle cells.
    Proc Natl Acad Sci U S A. 1988 Aug;85(15):5728-32 PMID: 2456580
  11. A re-examination of the localization of immunoreactive dynorphin(1-8), [Leu]enkephalin and [Met]enkephalin in the rat neurohypophysis.
    Neuroscience. 1987 Mar;20(3):1069-80 PMID: 2885779
  12. Physiological regulation of neurohypophyseal kappa-opiate receptors.
    Brain Res. 1988 Mar 8;443(1-2):398-402 PMID: 2896058
  13. Effect of isolation stress on concentrations of arginine vasopressin, alpha-melanocyte-stimulating hormone and ACTH in the pituitary venous effluent of the normal horse.
    J Endocrinol. 1988 Mar;116(3):325-34 PMID: 2832503
  14. Corticotrophin-Releasing Hormone Stimulates Neurohypophyslal Hormone Release through an Interaction with the Intermediate Lobe of the Pituitary.
    J Neuroendocrinol. 1989 Feb;1(1):5-8 PMID: 19210475
  15. Decreased corticotropin-releasing factor-like immunoreactivity in rat intermediate and posterior pituitary after stalk section.
    Neuroendocrinology. 1984 Jul;39(1):93-5 PMID: 6611513
  16. Ability of the CRF immunoreactive neurons of the paraventricular nucleus to produce a vasopressin-like material. Immunohistochemical demonstration in adrenalectomized guinea pigs and rats.
    Neuroendocrinology. 1983 Dec;37(6):467-9 PMID: 6606790
  17. Opiate inhibition of peptide release from the neurohumoral terminals of hypothalamic neurones.
    Nature. 1979 Dec 13;282(5740):746-8 PMID: 574618
  18. Vasopressin coexists in half of the corticotropin-releasing factor axons present in the external zone of the median eminence in normal rats.
    Neuroendocrinology. 1987 May;45(5):420-4 PMID: 3295576
  19. Immunocytochemical detection of corticotropin-releasing factor: multiple cross-reactions of a widely used carboxy-terminally directed corticotropin-releasing factor antiserum (code rC70) in rat hypothalamus.
    Neuroscience. 1989;29(1):167-74 PMID: 2785248
  20. Calcitonin gene-related peptide regulates muscle acetylcholine receptor synthesis.
    Nature. 1986 Oct 30-Nov 5;323(6091):809-11 PMID: 3490625
  21. Dynorphin A decreases voltage-dependent calcium conductance of mouse dorsal root ganglion neurones.
    J Physiol. 1986 Aug;377:237-49 PMID: 2432242
  22. Methionine and leucine enkephalin in rat neurohypophysis: different responses to osmotic stimuli and T2 toxin.
    Science. 1985 May 3;228(4699):606-8 PMID: 2858918
  23. Release of alpha-melanocyte-stimulating hormone from dispersed cells of the intermediate lobe of the rat pituitary gland: involvement of catecholamines and adenosine 3',5'-monophosphate.
    Endocrinology. 1980 Jun;106(6):1795-803 PMID: 6245851
  24. Dynorphin 1-8 binds to opiate kappa receptors in the neurohypophysis.
    Neuroendocrinology. 1986;42(5):376-82 PMID: 2871501
  25. Corticotropin-releasing factor (CRF) and neurotransmitters modulate melanotropic peptide release from rat neurointermediate pituitary in vitro.
    Neuropeptides. 1988 Aug-Sep;12(2):59-66 PMID: 3263585
  26. Oxytocin release is inhibited by opiates from the neural lobe, not those from the intermediate lobe.
    Neurosci Lett. 1983 Dec 30;43(2-3):227-30 PMID: 6324042
  27. Dynorphin and vasopressin: common localization in magnocellular neurons.
    Science. 1982 Apr 2;216(4541):85-7 PMID: 6121376
  28. Corticotropin-releasing factor receptors and pituitary adrenal responses during immobilization stress.
    Endocrinology. 1988 Jul;123(1):396-405 PMID: 2838259
  29. Opiate receptors in rat pituitary are confined to the neural lobe and are exclusively kappa.
    Brain Res. 1986 Sep 24;382(2):365-71 PMID: 3019482
  30. Is there a "final common pathway" in the regulation of ACTH release?
    Adv Exp Med Biol. 1988;245:143-56 PMID: 2852456
  31. Do opioid peptides modulate, at the level of the nerve endings, the release of neurohypophysial hormones?
    Exp Brain Res. 1986;61(3):560-6 PMID: 3514253
  32. Dynorphin A inhibits and naloxone increases the electrically stimulated release of oxytocin but not vasopressin from the terminals of the neural lobe.
    Endocrinology. 1988 Apr;122(4):1321-7 PMID: 2894296
  33. Corticotropin-releasing factor-immunoreactive neurons of the paraventricular nucleus become vasopressin positive after adrenalectomy.
    Proc Natl Acad Sci U S A. 1984 Mar;81(6):1854-8 PMID: 6608732
  34. Dissociation of the adrenocorticotropin secretory responses to corticotropin-releasing factor (CRF) and vasopressin or oxytocin by using a specific cytotoxic analog of CRF.
    Endocrinology. 1988 Apr;122(4):1695-700 PMID: 2831039
  35. Cholecystokinin evokes secretion of oxytocin and vasopressin from rat neural lobe independent of external calcium.
    Proc Natl Acad Sci U S A. 1989 Jul;86(13):5198-201 PMID: 2740351
  36. Are single retinal neurons both excitatory and inhibitory?
    Nature. 1988 Dec 8;336(6199):517-8 PMID: 3200304
  37. CRF stimulates alpha-MSH secretion and cyclic AMP accumulation in rat pars intermedia cells.
    Life Sci. 1982 Nov 8;31(19):2129-35 PMID: 6294429
  38. Evidence for a kappa-opioid receptor on pituitary astrocytes: an autoradiographic study.
    Neurosci Lett. 1985 Apr 19;55(3):317-23 PMID: 2989733
  39. Analysis of peptide histidine-isoleucine/vasoactive intestinal polypeptide-immunoreactive neurons in the central nervous system with special reference to their relation to corticotropin releasing factor- and enkephalin-like immunoreactivities in the paraventricular hypothalamic nucleus.
    Neuroscience. 1987 Dec;23(3):827-57 PMID: 3125490
  40. Opiate binding differentially associated with oxytocin and vasopressin nerve endings from porcine neurohypophyses.
    Exp Brain Res. 1988;70(1):145-54 PMID: 3402560
  41. Regulation of hypothalamic magnocellular neuropeptides and their mRNAs in the Brattleboro rat: coordinate responses to further osmotic challenge.
    J Neurosci. 1988 Oct;8(10):3785-96 PMID: 2903913
  42. Cholecystokinin in the hypothalamo-hypophyseal system.
    Brain Res. 1984 May 7;299(1):186-9 PMID: 6722568
  43. Regulation of hypophysiotropic factors mediating ACTH secretion.
    Ann N Y Acad Sci. 1987;512:205-17 PMID: 2831776
  44. Immunohistochemical localization of cholecystokinin- and gastrin-like peptides in the brain and hypophysis of the rat.
    Proc Natl Acad Sci U S A. 1980 Feb;77(2):1190-4 PMID: 6987667
  45. The effects of adrenalectomy and glucocorticoid replacement on vasopressin and vasopressin-neurophysin in the zona externa of the median eminence of the rat.
    Endocrinology. 1977 Jul;101(1):42-9 PMID: 862561
  46. Opioid binding in a rat neurohypophysial fraction enriched in oxytocin and vasopressin nerve endings.
    Neurosci Lett. 1985 Oct 24;61(1-2):37-41 PMID: 2867504
  47. Corticotropin-releasing factor receptors in the pituitary gland and central nervous system: methods and overview.
    Methods Enzymol. 1986;124:560-90 PMID: 3012254
  48. Dynorphin-A-(1-8) is contained within vasopressin neurosecretory vesicles in rat pituitary.
    Science. 1983 Dec 9;222(4628):1137-9 PMID: 6648526
  49. Vasopressin, oxytocin, dynorphin, enkephalin and corticotrophin-releasing factor mRNA stimulation in the rat.
    J Physiol. 1987 Dec;394:23-39 PMID: 2895179
  50. A functional role for opioid peptides in the differential secretion of vasopressin and oxytocin.
    Brain Res. 1984 Sep 10;309(2):362-6 PMID: 6541075
  51. Autoradiographic localization of brain receptors for peptide hormones: angiotensin II, corticotropin-releasing factor, and gonadotropin-releasing hormone.
    Methods Enzymol. 1986;124:590-606 PMID: 3012255
  52. Comparative immunoelectron microscopic localization of corticotropin-releasing factor (CRF-41) and oxytocin in the rat median eminence.
    Neuroendocrinology. 1984 Sep;39(3):284-7 PMID: 6334245
  53. Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotropin-releasing factor.
    Endocr Rev. 1986 Nov;7(4):351-78 PMID: 3023041
  54. Major pro-vasopressin-expressing and pro-vasopressin-deficient subpopulations of corticotropin-releasing hormone neurons in normal rats. Differential distributions within the paraventricular nucleus.
    Neuroendocrinology. 1988 Feb;47(2):176-80 PMID: 3257815
  55. Multiple chemical messengers in hypothalamic magnocellular neurons.
    Prog Brain Res. 1986;68:161-8 PMID: 2882551
  56. Dynorphin (1-8) inhibits stimulated release of oxytocin but not vasopressin from isolated neurosecretory endings of the rat neurohypophysis.
    Neuropeptides. 1988 May-Jun;11(4):163-7 PMID: 2901684
  57. Comparative immunocytochemical localization of corticotropin releasing factor (CRF-41) and neurohypophysial peptides in the brain of Brattleboro and Long-Evans rats.
    Neuroendocrinology. 1983 Jul;37(1):64-72 PMID: 6604239
  58. Ultrastructural manifestations of increased hormone release in the neurohypophysis.
    Prog Brain Res. 1983;60:259-72 PMID: 6665143
  59. Effect of axonal transport blockade on corticotropin-releasing factor immunoreactivity in the median eminence of intact and adrenalectomized rats: relationship between depletion rate and secretory activity.
    Brain Res. 1988 Mar 1;442(2):312-20 PMID: 2453250
  60. Cotransmission.
    Annu Rev Pharmacol Toxicol. 1987;27:51-70 PMID: 2883929
  61. Localization and actions of cholecystokinin in the rat pituitary neurointermediate lobe.
    Endocrinology. 1984 May;114(5):1902-11 PMID: 6325136
  62. Effects of opioid agonists and antagonists on oxytocin and vasopressin release in vitro.
    Neuroendocrinology. 1985 Aug;41(2):142-8 PMID: 2864649
  63. Characteristics and regulation of angiotensin II receptors in pituitary, circumventricular organs and kidney.
    Clin Exp Hypertens A. 1983;5(7-8):1081-97 PMID: 6315266
  64. Ontogeny of opioid inhibition of vasopressin and oxytocin release in response to osmotic stimulation.
    Endocrinology. 1986 Jul;119(1):1-11 PMID: 3720659
  65. Corticotrophin releasing factor may be modulated vasopressin.
    Nature. 1979 Mar 29;278(5703):463-4 PMID: 313009
  66. Co-expression of corticotropin-releasing factor and vasopressin immunoreactivity in parvocellular neurosecretory neurons of the adrenalectomized rat.
    Proc Natl Acad Sci U S A. 1984 Mar;81(6):1883-7 PMID: 6369332
  67. Temporal changes in the activity of endogenous opioid mechanisms regulating oxytocin secretion in saline-loaded rats.
    Neurosci Lett. 1987 Nov 23;82(2):191-5 PMID: 3696493
  68. Distributions of pro-vasopressin expressing and pro-vasopressin deficient CRH neurons in the paraventricular hypothalamic nucleus of colchicine-treated normal and adrenalectomized rats.
    J Comp Neurol. 1988 Sep 1;275(1):13-28 PMID: 3262632
  69. Receptors and cell activation associated with pancreatic enzyme secretion.
    Annu Rev Physiol. 1986;48:103-17 PMID: 2423019
  70. The cellular actions of vasopressin on corticotrophs of the anterior pituitary: resistance to glucocorticoid action.
    Mol Endocrinol. 1987 Jul;1(7):451-8 PMID: 3153472
  71. Oxytocin secretion in response to cholecystokinin and food: differentiation of nausea from satiety.
    Science. 1986 Jun 13;232(4756):1417-9 PMID: 3715453
  72. Corticotropin-releasing factor: co-expression within distinct subsets of oxytocin-, vasopressin-, and neurotensin-immunoreactive neurons in the hypothalamus of the male rat.
    J Neurosci. 1984 Apr;4(4):1118-29 PMID: 6609226
  73. Co-localization of corticotropin releasing factor and vasopressin mRNA in neurones after adrenalectomy.
    Nature. 1985 May 2-8;315(6014):59-61 PMID: 3873012
  74. Characterization of kappa opioid receptors in neurosecretosomes from bovine posterior pituitary.
    J Neurochem. 1987 Aug;49(2):421-7 PMID: 3037028
  75. Stress selectively activates the vasopressin-containing subset of corticotropin-releasing hormone neurons.
    Neuroendocrinology. 1989 Dec;50(6):702-7 PMID: 2515467
  76. Endogenous opiates regulate oxytocin but not vasopressin secretion from the neurohypophysis.
    Nature. 1982 Jul 8;298(5870):161-2 PMID: 7088170
  77. Co-localization of corticotropin-releasing factor and vasopressin in median eminence neurosecretory vesicles.
    Nature. 1985 Sep 19-25;317(6034):248-50 PMID: 3900740
  78. Biphasic inhibition of adrenocorticotropin release by corticosterone in cultured anterior pituitary cells.
    Endocrinology. 1986 Sep;119(3):972-7 PMID: 3015577
  79. Regulation of the release of coexisting neurotransmitters.
    Annu Rev Pharmacol Toxicol. 1988;28:285-310 PMID: 2898236
  80. Characterization of corticosterone feedback regulation of ACTH secretion.
    Ann N Y Acad Sci. 1987;512:402-14 PMID: 2831781
  81. Functional kappa-opioid receptors on oxytocin and vasopressin nerve terminals isolated from the rat neurohypophysis.
    Brain Res. 1988 Oct 11;462(1):62-6 PMID: 2902908
Article Info
Journal
Cellular and molecular neurobiology
Abbr.
Cell Mol Neurobiol
ISSN
0272-4340
Published
1989-12-00
Pages
427-46
Language
English
Region
United States
NLM ID
8200709
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com